Home › Stocks › MDGL › All Fund Holders
MDGL — MADRIGAL PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 47 · Reported value held: $6.27B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 1.81M | $1.05B | 0.01% | Hold |
| Janus Henderson Group history | Q1 2026 | 2.02M | $1.05B | 0.52% | Add |
| Paulson & Co history | Q2 2026 | 1.34M | $719.52M | 27.93% | Reduce |
| BlackRock Inc history | Q2 2026 | 1.20M | $644.75M | 0.01% | Reduce |
| Wellington Management Group history | Q2 2026 | 825.71K | $443.37M | 0.08% | Add |
| Citadel Advisors history | Q2 2026 | 688.13K | $369.49M | 0.04% | Add |
| UBS Group AG history | Q2 2026 | 401.71K | $215.70M | 0.03% | Add |
| Geode Capital Management history | Q2 2026 | 374.88K | $201.34M | 0.01% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 356.20K | $191.26M | 0.01% | Reduce |
| Invesco Ltd history | Q2 2026 | 301.44K | $161.86M | 0.01% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 246.28K | $132.24M | 0.01% | Reduce |
| Norges Bank Investment Management history | Q2 2026 | 213.89K | $114.85M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 184.32K | $98.97M | 0.01% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 162.27K | $87.13M | 0.04% | Add |
| Point72 Asset Management history | Q2 2026 | 142.63K | $76.58M | 0.09% | Reduce |
| Morgan Stanley history | Q2 2026 | 139.01K | $74.64M | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 134.04K | $71.97M | 0.01% | Reduce |
| BNY Mellon history | Q2 2026 | 128.52K | $69.01M | 0.01% | Reduce |
| Millennium Management history | Q2 2026 | 118.50K | $63.63M | 0.02% | Add |
| Marshall Wace history | Q2 2026 | 101.86K | $54.69M | 0.04% | Add |
| Northern Trust Corp history | Q2 2026 | 98.51K | $52.89M | 0.01% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 83.92K | $45.06M | 0.01% | Reduce |
| Alkeon Capital Management history | Q2 2026 | 80.00K | $42.96M | 0.06% | Hold |
| Balyasny Asset Management history | Q2 2026 | 79.01K | $42.42M | 0.06% | New |
| Citigroup Inc history | Q2 2026 | 73.25K | $39.33M | 0.01% | Add |
| Renaissance Technologies history | Q2 2026 | 45.94K | $24.67M | 0.03% | Reduce |
| PSP Investments history | Q4 2025 | 32.87K | $19.14M | 0.06% | New |
| JPMorgan Chase & Co history | Q2 2026 | 29.47K | $16.01M | 0.00% | New |
| Steadfast Capital Management history | Q4 2025 | 26.85K | $15.64M | 0.27% | Reduce |
| CPP Investments history | Q2 2026 | 29.08K | $15.61M | 0.01% | Add |
| Wells Fargo & Co history | Q2 2026 | 26.54K | $14.25M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 15.83K | $8.50M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 12.35K | $6.63M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 12.20K | $6.55M | 0.01% | Reduce |
| Two Sigma Investments history | Q2 2026 | 10.47K | $5.62M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 9.32K | $5.00M | 0.00% | Reduce |
| Baron Funds history | Q2 2026 | 4.50K | $2.42M | 0.01% | Reduce |
| Bridgewater Associates history | Q1 2026 | 3.92K | $2.05M | 0.01% | Reduce |
| Farallon Capital Management history | Q1 2026 | 3.32K | $1.74M | 0.01% | Hold |
| Prudential Financial history | Q2 2026 | 2.68K | $1.44M | 0.00% | Reduce |
| Amundi US history | Q2 2026 | 1.39K | $744.21K | 0.00% | Add |
| Principal Global Investors history | Q1 2026 | 1.24K | $648.58K | 0.00% | Reduce |
| Soros Fund Management history | Q1 2024 | 2.02K | $538.35K | 0.01% | New |
| PNC Financial Services history | Q2 2026 | 885 | $475.20K | 0.00% | Add |
| Fidelity International (FIL) history | Q2 2024 | 1.61K | $449.94K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 187.23K | $100.53K | 0.01% | Reduce |
| Lazard Asset Management history | Q2 2025 | 256 | $77 | 0.00% | Hold |